Overview / Abstract: |
Are we waiting too long? It’s time to get off this ride to avoid the downward spiral of recurrent C. difficile. Paul Feuerstadt, MD, Teena Chopra, MD and Kevin Garey, PharmD, discuss the gut microbiota role, management of C. difficile infection in special populations, safety and efficacy of fecal microbiota transplantation, and emerging microbiota restoration therapies. |
Expiration |
Dec 08, 2021 |
Discipline(s) |
Pharmacy CPE, Physician CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1.25 |
Accreditation |
ACCME, ACPE |
Presenters / Authors / Faculty |
Teena Chopra, MD, MPH Paul Feuerstadt, MD, FACG, AGAF Kevin W. Garey, PharmD, MS, FASHP |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Ferring Pharmaceuticals, Inc. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, Live Meetings, Dr. Teena Chopra, Dr. Paul Feuerstadt, Dr. Kevin Garey C. difficile, CDI, live/virtual symposium, recurrence, FMT, MRT, IDWeek TM 2020, gut microbiome, recurrent, infections, infectious disease, gastroenterology, physician, fecal microbiota restoration, microbiota restoration therapy, IDSA Guidelines, special populations, Stem Cell Free CE CME |